NASDAQ:RPTP - Raptor Pharmaceutical Stock Price, News, & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Sign in or create an account to add this stock to your watchlist.
Previous Close$9.00
Today's Range$9.00 - $9.00
52-Week Range$2.94 - $9.05
VolumeN/A
Average Volume1.42 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Raptor Pharmaceutical Corp. (Raptor) is a biopharmaceutical company. The Company is focused on developing and commercializing transformative treatments for people affected by diseases. Its product, PROCYSBI (cysteamine bitartrate) is a delayed-release capsules for the management of nephropathic cystinosis in adults and children of over six years. In Europe, PROCYSBI gastro-resistant hard capsules of cysteamine (as mercaptamine bitartrate), is indicated as an orphan medicinal product for the management of nephropathic cystinosis. Its QUINSAIR is a formulation of the antibiotic drug levofloxacin, suitable for inhalation via a nebulizer. It is engaged in developing MP-376 for non-CF bronchiectasis (BE) and nontuberculous mycobacteria (NTM) lung infections. It is also engaged in developing RP105 and RP106 for various diseases.

Receive RPTP News and Ratings via Email

Sign-up to receive the latest news and ratings for RPTP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryBiotechnology
SectorN/A
Current SymbolNASDAQ:RPTP
CUSIP75382F10
Phone+1-415-4086200

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableOptionable

Raptor Pharmaceutical (NASDAQ:RPTP) Frequently Asked Questions

What is Raptor Pharmaceutical's stock symbol?

Raptor Pharmaceutical trades on the NASDAQ under the ticker symbol "RPTP."

Has Raptor Pharmaceutical been receiving favorable news coverage?

Media headlines about RPTP stock have been trending somewhat negative recently, InfoTrie reports. The research firm identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Raptor Pharmaceutical earned a news impact score of -1.6 on InfoTrie's scale. They also gave news articles about the biotechnology company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the near future.

What other stocks do shareholders of Raptor Pharmaceutical own?

What is Raptor Pharmaceutical's official website?

The official website for Raptor Pharmaceutical is http://www.horizonpharma.com/.

How can I contact Raptor Pharmaceutical?

Raptor Pharmaceutical's mailing address is 7 Hamilton Lndg Ste 100, NOVATO, CA 94949-8283, United States. The biotechnology company can be reached via phone at +1-415-4086200.


MarketBeat Community Rating for Raptor Pharmaceutical (NASDAQ RPTP)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  253 (Vote Outperform)
Underperform Votes:  269 (Vote Underperform)
Total Votes:  522
MarketBeat's community ratings are surveys of what our community members think about Raptor Pharmaceutical and other stocks. Vote "Outperform" if you believe RPTP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RPTP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel